Purpose The purpose of the study is to investigate the effect of an emotional intelligence program on the health-related quality of life and well-being of individuals with type 2 diabetes.
Methods The BarOn Emotional Intelligence Scale (EQ-I), WHO Well-Being Questionnaire (WHO-WBQ-22), WHO Quality of Life Measure (WHOQOL-Bref), and the Medical Outcomes Study 36-Item Health Survey (SF-36) were administered to 184 patients with type 2 diabetes who volunteered to participate. Thirty-six patients with the lowest test scores on the WHO-WBQ-22, WHOQOL-Bref, and SF-36 were randomized into study and control groups (18 patients each). A 12-week emotional intelligence program was administered to the study group. At the end of the program, scales were readministered to both groups and again at 3 and 6 months.
Results There were no differences between the quality of life, well-being, and emotional intelligence levels of the study and control groups before the commencement of the program ( P > .05). At the conclusion of the program, quality of life, well-being, and emotional intelligence levels of study group patients increased in comparison with those in the control group (P < .001). The positive effect of the program on study groups' quality of life, wellbeing, and emotional intelligence persisted at the 3- and 6-month follow-up.
Conclusion The emotional intelligence program may have positive effects on quality of life and well-being of individuals with type 2 diabetes.
Get full access to this article
View all access options for this article.
References
1.
Rose M., Flege H., Hilderbandt M., et al. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care. 2002;25(1):35-42.
2.
Norris AL, Engelgau MM, Narayan KMV.Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trails. Diabetes Care. 2001;24(3):561-587.
3.
Polonsky HWUnderstanding and assessing diabetes specific quality of life. Diabetes Spectrum. 2000;13:36.
4.
Knoll MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta-analysis. Diabetologia. 2006 ;49(5):837-845.
5.
Golden SH, Williams JE, Ford DE, et al. Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2004;27(2):429-435.
Davis WK, Hess GE, Van Harrison R., et al. Psychosocial adjustment to and control of diabetes mellitus: differences by disease type and treatment. Health Psychol . 1987;6:1-14.
8.
Goleman D.Emotional Intelligence. New York, NY: Bantam Books; 1995.
9.
Glaskow RE, Toobert DJ, Hampson S., et al. Improving self-care among older patients with type II diabetes: The "Sixty Something . . ." study. Patients Educ Counsel. 1992;19:61-74.
10.
Anderson B. , Finkelstein D., Laffel L.Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin related diabetes mellitus . J Pediatr. 1997;130:257-265.
11.
Glaskow RE, Toobert DJSocial environment and regimen adherence among type II diabetic patients . Diabetes Care. 1988;11:377-385.
12.
Hanson CL, de Guire MJ, Schinkel AMEmpirical validation for a family-centered model of care. Diabetes Care. 1995;18:1347-1356.
13.
Testa MA, Simonson DCAssessment of quality-of-life outcomes. N Engl J Med . 1996;334:835-840.
14.
Wilson IB, Cleary PDLinking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1996;273:59-65.
15.
Hanninen JA , Takala JK, Keinanen-Kiukaaniemi S.Depression in subjects with type 2 diabetes: predictive factors and relation to quality of life. Diabetes Care;1999;22:997-998.
16.
Rose M., Burkert U., Scholler G., et al. Determinants of the quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care. 1998;21:1876-1885.
17.
Korhonen T. , Huttunen J., Aro A., et al. A controlled trial on the effects of patient education in treatment of insulin dependent diabetes. Diabetes Care. 1983;6:256-261.
18.
Lockington T., Farrant S., Meadow K., et al. Knowledge profile and control in diabetic patients. Diabet Med. 1988;5:381-386.
19.
Nomura M., Fujimoto K., Higashino A., et al. Stress and coping behavior in patients with diabetes mellitus . Acta Diabetol. 2000;37:61-64.
20.
Grey M., Boland EA, Davidson M., et al. Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care. 1998 ;21:902-908.
21.
Gilden JL, Casia C., Hendryx M., et al. Effects of self-monitoring of blood glucose on quality of life in elderly diabetic patients. J Am Geriatr Soc. 1990;38:511-515.
22.
Grey M., Boland EA, Davidson M., et al. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000;137:107-113.
23.
Scott R., Beaven D., Stafford J.The effectiveness of diabetes education for non-insulin-dependent diabetic persons. Diabetes Educ. 1984;10:36-39.
24.
de Weerdt I. , Visser A., Kok G., et al. Randomized controlled evaluation of an educational programme for insulin treated patients with diabetes: effects on psychosocial variables. Patient Educ Couns. 1989;14:191-215.
25.
Winkley K., Landau S., Eisler I., et al. Psychological interventions to improve glycaemic control in patients with type I diabetes: systemic review and meta-analyses of randomized controlled trials. BMJ. 2006;333:65-68.
26.
Adili F., Larijani B., Haghighatpanah M.Diabetic patients: psychological aspects. Ann NY Acad Sci . 2006;1084:329-349.
27.
van der Ven N.Psychosocial group interventions in diabetes care. Diabetes Spectrum. 2003;16(2):88-95.
28.
Mayer JD, Salovey, P., Caruso DR, Sitarenios G.Emotional intelligence as standard intelligence. Emotion. 2001;1(3):232-242.
29.
Mayer JD, Salovey P.What Is Emotional Intelligence? Emotional Development and Emotional Intelligence . New York, NY: Basic Books; 1997.
30.
Goleman D.Why Is Emotional Intelligence More Important Than IQ? Banu S, trans . 7th ed. Yüksel, Turkey: Varlık/Bilim Press; 1998.
31.
Weisinger H.Emotional Intelligence in Business Life. Süleymangil N, trans. Istanbul, Turkey: MNS Press; 1998 .
32.
Shapiro LETo Raise a Child With a Superior EQ. Kartal Ü, trans. Istanbul, Turkey: Varlık Press; 1998.
Matthews G., Zeidner M.The Handbook of Emotional Intelligence: Theory, Development, Assessment and Application at Home, School and in the Workplace. Bar-On R, Parker JDA, eds. San Francisco, CA: Jossey-Bass; 2000:459.
35.
Bar-On R.The Emotional Quotient Inventory (EQ-I): A Test of Emotional Intelligence. Toronto, Canada: Multi-Health Systems; 1997
Bar-On R.Emotional and social intelligence: insights from the Emotional Quotient Inventory (EQ-I). In: Bar-On R, Parker JDA, eds. Handbook of Emotional Intelligence. San Francisco, CA: Jossey-Bass, 2000:15-80.
38.
Bar-On R.The Bar-On Emotional Quotient Inventory (EQ-I): rationale, description, and summary of psychometric properties. In: Geher G, ed. Measuring Emotional Intelligence: Common Ground and Controversy. Hauppauge, NY: Nova Science;2004:111-142.
39.
Bar-On R.The Bar-On model of emotional-social intelligence (ESI). Psicothema. 2006;18(suppl):13-25.
40.
Mumcuoglu O.The Validity and Reliability of the Bar-On Emotional Quotient Inventory to Turkish [dissertation]. Istanbul, Turkey: Marmara University, Institute of Educational Sciences, Department of Psychological Counseling and Guidance; 2002.
41.
Meadows P., Bradley C.Report to World Health Organization. Copenhagen , Denmark: European Office; 1990 .
42.
Fuhlendorff J. , Rorsman P., Kofod H., et al. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes . Diabetes. 1998;47:345-351.
43.
Bech P., Moses R., Gomis R.The effect of prandial glucose regulation with repaglinide on treatment satisfaction wellbeing and health status in patients with pharmacotherapy-naive type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res. 2003;12:413-425.
44.
Savlı H., Sevinc A.The evaluation of the Turkish version of the Well-Being Questionnaire (WBQ-22) in the patients with type 2 diabetes: the effects of diabetic complications. J Endocrinol Invest . 2005;28(8):683-691.
45.
Whoqol Group .Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551-558.
46.
Skevington SM, Lotfy M., O'Connell KA; the WHOQOL Group. The World Health Organisation's WHOQOL-Bref quality of life assessment: psychometric properties and the results of the international field trial. A report from the WHOQOL Group. Qual Life Res. 2004;13(2):299-310.
47.
Eser E., Fidaner H., Fidaner C., et al. WHOQOL-BREF TR, a suitable instrument for the assessment of quality of life for use in the health care settings in Turkey [abstract]. Qual Life Res. 1999;8(7):647. Abstract 433.
48.
Ware JEHow to Score the Revised MOS Short Form Health Scale (SF-36). Boston, MA: The Health Institute, New England Medical Center Hospitals; 1988.
49.
Kocyigit H. , Aydemir O., Olmez N., et al. The validity and reliability of the Turkish version of short form-(SF-36). J Med Treat. 1988;12:102-106.
50.
Scott KM, Tobias MI, Sarfati D., et al. SF-36 health survey reliability, validity and norms for New Zealand. Aust N Z J Public Health. 1999;23:401-406.
51.
Goleman D.Destructive Emotions: How Can We Overcome Them? A Scientific Dialogue With the Dalai Lama. New York, NY: Bantam Books; 2004
52.
Davis M. Eq: Measure Your Emotional Intelligence. Silahli S, trans. Istanbul, Turkey: Alfa Press; 2004 :5-136.
53.
Erkan S.Examples of Group Leadership Activities. 6th ed. Istanbul, Turkey: Pegem A Press; 2004:48-279.
54.
Blankstein AMLessons for life. EQ+IQ = best leadership practices for caring and successful schools. Elias MJ, Arnold H, Hussey CS, eds. Thousand Oaks, CA: Corwin Press; 2003:50-56.
55.
Altı nay D.Psychodrama: 400 Warming Games. 4th ed. Istanbul, Turkey: Sistem Press; 2003:35-267.
56.
Cooper RK, Sawaf A.Emotional Intelligence in Leadership. Istanbul , Turkey: Sistem Press; 2003.
57.
Konrad S., Hendl CASuccessful Life with Emotional Intelligence: To Be Empowered by Emotions. Taştan M, trans. Istanbul, Turkey: Hayat Press; 2003:9-166.
58.
Kulaksızoglu A.Applications for Personal Development. Istanbul , Turkey: Nobel Press; 2003.
59.
Selcuk Z., Güner N.Guidance Applications in Class. 3rd ed. Istanbul, Turkey: Pegem A Press; 2003:7-69.
60.
Stein SJ, Book HEEQ Emotional Intelligence and the Secret of Success. Isık M, trans . Istanbul, Turkey: Özgür Press ; 2003:35-77.
61.
Güney S.Behavioral Sciences. 2nd ed. Ankara, Turkey: Nobel Press; 2000 .
62.
Brockert S., Braun G.Using Your Emotional Intelligence. Süleymangil N, trans. Istanbul, Turkey: MNS Press; 2000 .
63.
Damasio ARDescartes' Error: Emotion, Cognition and the Human Brain. Atlamaz B, trans . 2nd ed. Istanbul, Turkey: Varılk/Bilim Press. 1999.
64.
Weisinger H.Emotional Intelligence in Business Life. Süleymangil N, trans. Istanbul, Turkey: MNS Press; 1998 .
65.
Burgoon JK, Buller DB, Woodall WGNonverbal Communication: The Unspoken Dialogue. 2nd ed. New York, NY: McGraw-Hill; 1996.
66.
Lustman PJ, Harper GWNonpsychiatric physicians' identification and treatment of depression in patients with diabetes. Compr Psychiatry. 1987;28:22-27.
67.
Snoek FJ, Skinner C.Psychological counseling in problematic diabetes: does it help? Diabet Med. 2002;19(4):265-273.
68.
Ismail K., Winkley K., Rabe-Hesketh S.Systemic review of randomized controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004;363:1589-1597.
69.
Anderson R. , Funnel M., Butler P., et al. Patient empowerment: results of a randomized controlled trial. Diabetes Care. 1995;18:943-949.
70.
Gilden J., Hendryx M., Clar S., et al. Diabetes support groups improve health care of older diabetic patients. J Am Geriatr Soc. 1992;40:147-150.
71.
Glaskow R., Toobert D., Mitchell D., et al. Nutrition education and social learning interventions for type II diabetes. Diabetes Care. 1989;12:150-152.
72.
Lorenz RA, Bubb J., Davis D., et al. Changing behaviour: practical lessons from the diabetes control and complications trialDiabetes Care.1996 ;19;648-652.
73.
Harvey A., Watkins E., Mansell W., et al. Cognitive Behavioural Processes Across Psychological Disorders: A Transdiagnostics Approach to Research and Treatment. New York, NY: Oxford University Press; 2004.
74.
Neenan M.Cognitive Behavioural Therapy: An A-Z of Persuasive Arguments. Philadelphia, PA: Whurr;2005.
75.
Rubin RR, Peyrot M.Psychosocial problems and interventions: a review of the literature . Diabetes Care. 1992;15:1640-1657.
76.
Rubin RR, Peyrot M.Psychological issues and treatments for people with diabetes. J Clin Psychol. 2001;57:457-478.
77.
Anderson L.Health-care communication and selected psychosocial correlates of adherence in diabetes management. Diabetes Care . 1990;13:66-77.
78.
Von Korff M. , Gruman J., Schaefer J., et al. Collaborative management of chronic illness. Ann Intern Med. 1997;127:1097-1102.
79.
Dolan Mullen P., Green L., Persinger G.Clinical trails of patient education for chronic conditions: a comparative meta-analyses of intervention types. Prev Med. 1985;14:753-781.
